Statement Of Income

Fuji Pharma Co.,Ltd. - Filing #7712320

Concept	2018-10-01 to 2019-03-31	2017-10-01 to 2018-03-31
Statement of income
Statement of income
Net sales	18,483,000,000 JPY	17,961,000,000 JPY
Net sales
Operating revenue
Cost of sales
Cost of sales	10,561,000,000 JPY	10,042,000,000 JPY
Operating expenses
Research and development expenses	699,000,000 JPY	913,000,000 JPY
Operating expenses
Selling, general and administrative expenses	5,454,000,000 JPY	5,644,000,000 JPY
Operating profit (loss)	2,467,000,000 JPY	2,275,000,000 JPY
Gross profit (loss)	7,921,000,000 JPY	7,919,000,000 JPY
Ordinary profit (loss)	2,501,000,000 JPY	2,360,000,000 JPY
Gross profit
Non-operating income
Interest income	2,000,000 JPY	0 JPY
Selling, general and administrative expenses
Extraordinary income	1,000,000 JPY	3,000,000 JPY
Non-operating income
Non-operating income	136,000,000 JPY	113,000,000 JPY
Financial revenue	—	—
Other	13,000,000 JPY	33,000,000 JPY
Non-operating expenses
Interest expenses	19,000,000 JPY	20,000,000 JPY
Non-operating expenses
Non-operating expenses	101,000,000 JPY	28,000,000 JPY
Financial expenses	—	—
Non-operating expenses
Other	0 JPY	3,000,000 JPY
Sales discounts	5,000,000 JPY	3,000,000 JPY
Extraordinary losses	2,000,000 JPY	3,000,000 JPY
Extraordinary income
Gain on sale of non-current assets	1,000,000 JPY	3,000,000 JPY
Profit (loss) before income taxes	2,499,000,000 JPY	2,360,000,000 JPY
Income taxes - current	653,000,000 JPY	476,000,000 JPY
Extraordinary losses
Loss on sale of non-current assets	0 JPY	0 JPY
Loss on retirement of non-current assets	2,000,000 JPY	3,000,000 JPY
Income taxes - deferred	150,000,000 JPY	140,000,000 JPY
Income taxes	803,000,000 JPY	616,000,000 JPY
Profit (loss)	1,695,000,000 JPY	1,743,000,000 JPY